Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy

Clinical Endocrinology

Volumn 62, Issue 3, 2005, Pages 323-330

  Renehan, Andrew G ^a   Painter, John E ^b   Bell, G Duncan ^c   Rowland, Roger S ^c   O'Dwyer, Sarah T ^a   Shalet, Stephen M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b Royal Infirmary Sunderland   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGE; ARTICLE; BODY HEIGHT; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; INTESTINE LOOP; INTESTINE PERFORATION; LARGE INTESTINE; MAGNETIC ENDOSCOPIC IMAGING; MALE; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL ANALYSIS;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; CASE-CONTROL STUDIES; CECUM; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINE, LARGE; MALE; MASS SCREENING; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 15044343671     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02217.x     Document Type: Article

References (50)

1. Colao, A., Ferone, D., Marzullo, P. & Lombardi, G. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews, 25, 102-152.
2. Duncan, E. & Wass, J.A. (1999) Investigation protocol: acromegaly and its investigation. Clinical Endocrinology (Oxford), 50, 285-293.
3. Alexander, L., Appleton, D., Hall, R., Ross, W.M. & Wilkinson, R. (1980) Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology (Oxford), 12, 71-79.
4. Bates, A.S., Bullivant, B., Sheppard, M.C. & Stewart, P.M. (1999) Life expectancy following surgery for pituitary tumours. Clinical Endocrinology (Oxford), 50, 315-319.
5. Beauregard, C., Truong, U., Hardy, J. & Serri, O. (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology (Oxford), 58, 86-91.
6. Orme, S.M., McNally, R.J., Cartwright, R.A. & Belchetz, P.E. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism, 83, 2730-2734.
7. Wright, A.D., Hill, D.M., Lowy, C. & Fraser, T.R. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 39, 1-16.
8. Renehan, A.G., O'Connell, J., O'Halloran, D., Shanahan, F., Potten, C.S., O'Dwyer, S.T. & Shalet, S.M. (2003) Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Hormone and Metabolic Research, 35, 712-725.
9. Melmed, S. (2001) Acromegaly and cancer: not a problem? Journal of Clinical Endocrinology and Metabolism, 86, 2929-2934.
10. Renehan, A.G., O'Dwyer, S.T. & Shalet, S.M. (2001) Screening colonoscopy for acromegaly in perspective. Clinical Endocrinology (Oxford), 55, 731-733.
11. Bowles, C.J., Leicester, R., Romaya, C., Swarbrick, E., Williams, C.B. & Epstein, O. (2004) A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut, 53, 277-283.
12. Viiala, C.H., Zimmerman, M., Cullen, D.J. & Hoffman, N.B. (2003) Complication rates of colonoscopy in an Australian teaching hospital environment. International Medical Journal, 33, 355-359.
13. Wexner, S.D., Garbus, J.E. & Singh, J.J. (2001) A prospective analysis of 13,580 colonoscopies. Reevaluation of credentialing guidelines. Surgical Endoscopy, 15, 251-261.
14. Hall, C., Dorricott, N.J., Donovan, I.A. & Neoptolemos, J.P. (1991) Colon perforation during colonoscopy: surgical versus conservative management. British Journal of Surgery, 78, 542-544.
15. Flexi-Scope-Trial-Collaborators. (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet, 359, 1291-1300.
16. Winawer, S.J., Fletcher, R.H., Miller, L., Godlee, F., Stolar, M.H., Mulrow, C.D., Woolf, S.H., Click, S.N., Ganiats, T.G., Bond, J.H., Rosen, L., Zapka, J.G., Olsen, S.J., Giardiello, P.M., Sisk, J.E., Van Antwerp, R., Brown Davis, C., Marciniak, D.A. & Mayer, R.J. (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112, 594-642.
17. Colao, A., Balzano, A., Ferone, D., Panza, N., Grande, G., Marzullo, P., Bove, A., Iodice, G., Merola, B. & Lombardi, G. (1997) Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clinical Endocrinology (Oxford), 47, 23-28.
18. Delhougne, B., Deneux, C., Abstract, R., Chanson, P., Fierens, H., Laurent Puig, P., Duysburgh, I., Stevenaert, A., Tabarin, A. & Delwaide, J. (1995) The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. Journal of Clinical Endocrinology and Metabolism, 80, 3223-3226.
19. Jenkins, P.J., Besser, G.M. & Fairclough, P.D. (1999) Colorectal neoplasia in acromegaly. Gut, 44, 585-587.
20. Jenkins, P.J., Fairclough, P.D., Richards, T., Lowe, D.G., Monson, J., Grossman, A., Wass, J.A. & Besser, M. (1997a) Acromegaly, colonic polyps and carcinoma. Clinical Endocrinology (Oxford), 47, 17-22.
21. Veysey, M.J., Thomas, L.A., Mallet, A.I., Jenkins, P.J., Besser, G.M., Wass, J.A., Murphy, G.M. & Dowling, R.H. (1999) Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut, 44, 675-681.
22. Jenkins, P.J., Mills, T.D., Veysey, M.J., Fairclough, P.D., Wass, J.A. & Besser, G.M. (1997) Acromegaly is associated with colonomegaly correlates with tissue exposure to growth hormone and may be implicated in their increased risk of colorectal neoplasia. Journal of Endocrinology, 155 (Suppl. 2), OC22.
23. Bladen, J.S., Anderson, A.P., Bell, G.D., Rameh, B., Evans, B. & Heatley, D.J. (1993) Non-radiological technique for three-dimensional imaging of endoscopes. Lancet, 341, 719-722.
24. Rowland, R.S. & Bell, G.D. (1998) Non-radiological technique for 3D imaging of intestinal endoscopes: computerised graphical 3D representation of endoscope and skeleton. Medical and Biological Engineering and Computing, 36, 285-290.
25. Saunders, B.P., Bell, G.D., Williams, C.B., Bladen, J.S. & Anderson, A.P. (1995) First clinical results with a real time, electronic imager as an aid to colonoscopy. Gut, 36, 913-917.
26. Renehan, A.G., Bhaskar, P., Painter, J.E., O'Dwyer, S.T., Haboubi, N., Varma, J., Ball, S.G. & Shalet, S.M. (2000) The prevalence and characteristics of colorectal neoplasia in acromegaly. Journal of Clinical Endocrinology and Metabolism, 85, 3417-3424.
27. Rowland, R.S., Bell, G.D., Dogramadzi, S. & Allen, C. (1999) Colonoscopy aided by magnetic 3D imaging: is the technique sufficiently sensitive to detect differences between men and women? Medical and Biological Engineering and Computing, 37, 673-679.
28. Shah, S.G., Brooker, J.C., Williams, C.B., Thapar, C. & Saunders, B.P. (2000) Effect of magnetic endoscope imaging on colonoscopy performance: a randomised controlled trial. Lancet, 356, 1718-1722.
29. Shah, S.G., Saunders, B.P., Brooker, J.C. & Williams, C.B. (2000) Magnetic imaging of colonoscopy: an audit of looping, accuracy and ancillary maneuvers. Gastrointestinal Endoscopy, 52, 1-8.
30. Rajasoorya, C., Holdaway, I.M., Wrightson, P., Scott, D.J. & Ibbertson, H.K. (1994) Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology (Oxford), 41, 95-102.
31. Swearingen, B., Barker, F.G. 2nd, Katznelson, L., Biller, B.M., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P.M. & Zervas, N.T. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419-3426.
32. Dobrashian, R.D., O'Halloran, D.J., Hunt, A., Beardwell, C.G. & Shalet, S.M. (1993) Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clinical Endocrinology (Oxford), 38, 589-593.
33. Grinspoon, S., Clemmons, D., Swearingen, B. & Klibanski, A. (1995) Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. Journal of Clinical Endocrinology and Metabolism, 80, 927-932.
34. Trainer, P.J., Drake, W.M., Katznelson, L., Freda, P.U., Herman-Bonert, V., van der Lely, A.J., Dimaraki, E.V., Stewart, P.M., Friend, K.E., Vance, M.L., Besser, G.M., Scarlett, J.A., Thorner, M.O., Parkinson, C., Klibanski, A., Powell, J.S., Barkan, A.L., Sheppard, M.C., Malsonado, M., Rose, D.R., Clemmons, D.R., Johannsson, G., Bengtsson, B.A., Stavrou, S., Kleinberg, D.L., Cook, D.M., Phillips, L.S., Bidlingmaier, M., Strasburger, C.J., Hackett, S., Zib, K., Bennett, W.F. & Davis, R.J. (2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. New England Journal of Medicine, 342, 1171-1177.
35. Renehan, A.G., Toogood, A.A., Ryder, W.D., Jones, J., Potten, C.S., O'Dwyer, S.T. & Shalet, S.M. (2001) Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides. Clinical Endocrinology (Oxford), 55, 469-475.
36. Lissett, C.A., Peacey, S.R., Laing, I., Tetlow, L., Davis, J.R. & Shalet, S.M. (1998) The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clinical Endocrinology (Oxford), 49, 653-657.
37. Peacey, S.R., Toogood, A.A. & Shalet, S.M. (1998) Hypothalamic dysfunction in 'cured' acromegaly is treatment modality dependent. Journal of Clinical Endocrinology and Metabolism, 83, 1682-1686.
38. Rhodes, J.M. (2000) Colorectal cancer screening in the UK: Joint Position Statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland. Gut, 46, 746-748.
39. Cirocco, W.C. & Rusin, L.C. (1996) Fluoroscopy. A valuable ally during difficult colonoscopy. Surgical Endoscopy, 10, 1080-1084.
40. Williams, C.B., Saunders, B.P., Bell, G.D., Bladen, J.S., Gillies, D.F. & Guy, C.M. (1997) Real-time magnetic three-dimensional imaging of flexible endoscopy. Gastrointestinal Endoscopy Clinics of North America, 7, 469-475.
41. Shah, S.G., Thomas-Gibson, S., Lockett, M., Brooker, J.C., Thapar, C.J., Grace, I. & Saunders, B.P. (2003) Effect of real-time magnetic endoscope imaging on the teaching and acquisition of colonoscopy skills: results from a single trainee. Endoscopy, 35, 421-425.
42. Shah, S.G., Pearson, H.J., Moss, S., Kweka, E., Jalal, P.K. & Saunders, B.P. (2002) Magnetic endoscope imaging: a new technique for localizing colonic lesions. Endoscopy, 34, 900-904.
43. Painter, J., Saunders, D.B., Bell, G.D., Williams, C.B., Pitt, R. & Bladen, J. (1999) Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy, 31, 227-231.
44. Jenkins, P.J. & Besser, M. (2001) Acromegaly and cancer: a problem. Journal of Clinical Endocrinology and Metabolism, 86, 2935-2941.
45. Perry, I., Stewart, P.M. & Kane, K. (2003) Colorectal screening guidelines in acromegaly. Gut, 52, 1387.
46. Renehan, A.G. & Shalet, S.M. (2002) Acromegaly and colorectal cancer: risk assessment should be based on population-based studies. Journal of Clinical Endocrinology and Metabolism, 87.
47. Atkin, W.S. (2001) Risk of colorectal neoplasia in acromegaly: an independent view. Clinical Endocrinology (Oxford), 55, 723-725.
48. Luebeck, E.G. & Moolgavkar, S.H. (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America, 99, 15095-15100.
49. Moolgavkar, S.H. & Luebeck, E.G. (1992) Multistage carcinogenesis: population-based model for colon cancer. Journal of the National Cancer Institute, 84, 610-618.
50. Melmed, S., Vance, M.L., Barkan, A.L., Bengtsson, B.A., Kleinberg, D., Klibanski, A. & Trainer, P.J. (2002) Current status and future opportunities for controlling acromegaly. Pituitary, 5, 185-196.